Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties

Annamária Cseh, Jacques-Emmanuel Galimard, Josu de la Fuente, Antonella Isgro, Marco Zecca, Birgit Garwer, Alexandra Biffi, Mahmoud Aljurf, Mikael Sundin, Cristina Belendez, Franco Locatelli, Adriana Balduzzi, Sarah Lawson, Henrik Sengeloev, Marianne Ifversen, Riccardo Saccardi, Robert Wynn, Arjan C Lankester, Selim Corbacioglu, Christina Peters*

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties'. Together they form a unique fingerprint.

Medicine & Life Sciences